Adtalem Global Education

Adtalem reported Q2 2026 revenue of $503.4 million (up 12.4%) and adjusted earnings per share of $2.43 (expected $2.19). The adjusted EBITDA margin rose 290 basis points to 30.8% and student enrollment increased 6.3% to 97,010. The company raised its full-year guidance, completed a $150 million share buyback program and reports a solid balance sheet with net leverage of 0.9x. » More on de.investing.com

California-based Global IMC sold all 50,933 shares of Adtalem Global Education in Q3, a position worth about $6.48 million at quarter-average prices, according to an SEC filing. The exit reduced a holding that had been 1.7% of the fund’s assets and comes after Adtalem's stock surged nearly 70% earlier in the year before retreating. Adtalem recently reported revenue growth, higher adjusted EPS and enrollment gains, but shares fell on concerns about softer-than-expected growth. » More on finance.yahoo.com

Adtalem reported a 10.8% revenue increase in Q1 2026 to $462.3 million and adjusted earnings per share of $1.75 (+35.7%), beating analyst estimates. Total student enrollments rose 8.0% to 97,359, driven mainly by strong growth at Walden University, while Chamberlain saw margin setbacks. Adjusted EBITDA grew to $112.0 million, the adjusted EBITDA margin improved by 100 basis points, and trailing-12-month free cash flow was $319 million. Adtalem reaffirmed its full-year guidance of $1,900–$1,940 million in revenue and adjusted EPS of $7.60–$7.90; the company is relying on further enrollment growth, buybacks, and targeted healthcare partnerships. » More on de.investing.com

Adtalem Global Education’s shares rose to a new all-time high of $156.26; market capitalization is about $5.6 billion. Year to date the stock is up 115.31%, supported by revenue growth of 12.85%. For fiscal Q4 2025 the company reported EPS of $1.66 versus $1.53 expected and revenue of $457.1 million (expectation $440.1 million). Despite the strong numbers the stock slipped slightly in after-hours trading, though analysts see further upside potential. » More on de.investing.com

At the Jefferies Healthcare Services Conference, Adtalem presented its strategy to expand access to health education to address the shortage of skilled workers. The company is targeting mid-single-digit revenue growth and further margin expansion in the medium term and reported free cash flow of $330 million last year. Operatively, Adtalem serves about 90,000 students; growth drivers include partnerships, expansion in allied-health areas and targeted bolt-on acquisitions. Regulatory changes are to be offset by alternative financing options for students. » More on de.investing.com